CARLSBAD, Calif., Jan. 4, 2023
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today
announced that Brett P. Monia,
Ph.D., chief executive officer, will present a company overview and
participate in a Q&A session at the 41st Annual J.P.
Morgan Healthcare Conference at 9:45 a.m.
PT (12:45 p.m. ET) on
Wednesday, January 11, 2023.
A live webcast of the presentation and Q&A session will be
available on the Investors & Media section of the Ionis
website. The replay will be available within 48 hours and will be
archived for a limited time.
About Ionis Pharmaceuticals,
Inc.
For more than 30 years, Ionis has been the leader in
RNA-targeted therapy, pioneering new markets and changing standards
of care with its novel antisense technology. Ionis currently has
three marketed medicines and a premier late-stage pipeline
highlighted by industry-leading cardiovascular and neurological
franchises. Our scientific innovation began and continues with the
knowledge that sick people depend on us, which fuels our vision of
becoming a leading, fully integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and follow
us on Twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-41st-annual-jp-morgan-healthcare-conference-301712823.html
SOURCE Ionis Pharmaceuticals, Inc.